Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin 2.5 mg BID vs 5 mg QD add-on to Metformin
NCT01012037Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Boehringer Ingelheim. Started Nov 2009; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01012037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01012037.